(Hypertension. 2000;36:638.)
© 2000 American Heart Association, Inc.
Colin Johnston - A Celebration |
Hypothesis Regarding the Pathophysiological Role of Alternative Pathways of Angiotensin II Formation in Atherosclerosis
From the Department of Internal Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan.
Correspondence to Hidenori Urata, MD, Department of Internal Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan. E-mail uratah{at}fukuoka-u.ac.jp
Abstract—The renin-angiotensin system has been studied and recognized as one of the major blood pressure–regulating systems for the past century. In the last quarter century, however, many alternative pathways of angiotensin II formation have been found, and among them, chymase has been a focus of interest because of its specificity and potency in the human cardiovascular system. Chymase evidently is not involved in functional regulation of blood pressure at least in the short term, but evidence is accumulating that it may be involved in structural remodeling of the cardiovascular system. We found increased vascular chymase activity in atherosclerotic lesions of the human aorta as well as in cardiac remodeling after myocardial infarction. We found a significant positive correlation between serum total or LDL cholesterol levels and arterial chymase-dependent angiotensin II–forming activity in patients who were undergoing coronary artery bypass operation, suggesting that high serum cholesterol may trigger upregulation of vascular chymase and facilitate the development of atherosclerosis. This hypothesis was tested in Syrian hamsters fed a high cholesterol diet containing 0.5% cholesterol: A marked lipid deposition in the aortic cusp developed and the plasma cholesterol levels were positively correlated with aortic chymase activity. An orally active nonpeptide chymase inhibitor almost canceled this lipid deposition. These clinical and experimental data indicated an association between cholesterol and vascular chymase upregulation that may facilitate the development of atherosclerosis.
Key Words: kallikrein • angiotensin-converting enzyme • atherosclerosis • cardiovascular diseases
This article has been cited by other articles:
 |
|
 |
|
  C. Yu, R. Gong, A. Rifai, E. M. Tolbert, and L. D. Dworkin Long-Term, High-Dosage Candesartan Suppresses Inflammation and Injury in Chronic Kidney Disease: Nonhemodynamic Renal Protection J. Am. Soc. Nephrol., March 1, 2007; 18(3): 750 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Uehara, H. Urata, M. Ideishi, K. Arakawa, and K. Saku Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta Cardiovasc Res, September 1, 2002; 55(4): 870 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Bagby, L. S. LeBard, Z. Luo, R. C. Speth, B. E. Ogden, and C. L. Corless Angiotensin II Type 1 and 2 Receptors in Conduit Arteries of Normal Developing Microswine Arterioscler. Thromb. Vasc. Biol., July 11, 2002; 22(7): 1113 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Iwamoto, K. Song, S. Takai, M. Yamada, D. Jin, M. Sakaguchi, H. Ueda, Y. Katsuoka, and M. Miyazaki Multiple Pathways of Angiotensin I Conversion and Their Functional Role in the Canine Penile Corpus Cavernosum J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 43 - 48. [Abstract] [Full Text]
|
|